Radiation Therapy for Multiple Myeloma

 

Radiation therapy (also called radiotherapy) uses high-energy rays to destroy myeloma cells and to help control pain. You would receive radiation therapy at a hospital or clinic. A large machine aims radiation at the bone or the part of the body where myeloma cells have collected. It is local therapy because it affects cells only in the treated area.

Radiation therapy is the main treatment for people with solitary plasmacytoma, a collection of myeloma cells in one area of bone or tissue. Patients typically receive radiation to the affected area of the body for 4 to 5 weeks.

Radiation is sometimes used in other ways for patients with multiple myeloma:

  • To control tumor growth throughout the body – High doses of radiation, given to a larger area of the body, can be used to control the growth of tumors in bones.
  • To relieve pain – Low doses of radiation therapy can be helpful in relieving pain caused by bone tumors.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Multiple Myeloma News
US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

FDA staff unsure about new use for Amgen's Xgeva

February 6, 2012 — WASHINGTON (Reuters) - Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc's Xgeva bone drug should be approved for a wider use of delaying the spread of cancer to the bone.

J&J sees continued supply shortages of cancer drug

September 27, 2011 —

Select news items provided by Reuters Health